Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck
Vassiliki Saloura, Hyun‐Soo Cho, Kazuma Kiyotani, et al.
Molecular Cancer Research (2014) Vol. 13, Iss. 2, pp. 293-304
Open Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis
Zilong Yan, Qingen Da, Zhangfu Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies
Lavinia Ghiani, Susanna Chiocca
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3483-3483
Open Access | Times Cited: 23
NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
Iuliia Topchu, Igor Bychkov, Demirkan Gursel, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
In silico study to identify novel NEK7 inhibitors from natural sources by a combination strategy
Heng Zhang, Chenhong Lu, Qilong Yao, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 5
The NIMA-related kinase family and cancer
Haotian Li, Junhan Li, Yue Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1
Yuichiro Yoshioka, Takehiro Suzuki, Yo Matsuo, et al.
Oncotarget (2016) Vol. 7, Iss. 46, pp. 75023-75037
Open Access | Times Cited: 46
NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases
Jin Xu, Liqun Lu, Lanfang Li
Acta Biochimica et Biophysica Sinica (2016) Vol. 48, Iss. 10, pp. 966-968
Open Access | Times Cited: 43
miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation
Peixin Dong, Ying Xiong, Junming Yue, et al.
Oncotarget (2018) Vol. 9, Iss. 33, pp. 23253-23263
Open Access | Times Cited: 43
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
Vassiliki Saloura, Theodore Vougiouklakis, Makda Zewde, et al.
Oncotarget (2016) Vol. 7, Iss. 27, pp. 42527-42538
Open Access | Times Cited: 39
Inhibition of SETMAR–H3K36me2–NHEJ repair axis in residual disease cells prevents glioblastoma recurrence
Ekjot Kaur, Jyothi Nair, Atanu Ghorai, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 12, pp. 1785-1796
Open Access | Times Cited: 32
Identification of NEK7 inhibitors: structure based virtual screening, molecular docking, density functional theory calculations and molecular dynamics simulations
Mubashir Aziz, Syeda Abida Ejaz, Hafiz Muzzammel Rehman, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6894-6908
Open Access | Times Cited: 19
Recent Advances in Targeting Histone H3 Lysine 36 Methyltransferases for Cancer Therapy
Sai Ma, Guanlu Long, Zheng Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116532-116532
Closed Access | Times Cited: 4
Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7
Jiayun Yu, H Li, Yongyao Wu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 25
Open Access | Times Cited: 4
Lentiviral vector‐mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome
Arun Kumar Nalla, Theodore F. Williams, Casey P. Collins, et al.
Molecular Carcinogenesis (2015) Vol. 55, Iss. 11, pp. 1761-1771
Open Access | Times Cited: 40
The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
Vassiliki Saloura, Theodore Vougiouklakis, Cem Sievers, et al.
Oral Oncology (2018) Vol. 81, pp. 100-108
Open Access | Times Cited: 32
<p>The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors</p>
Rui Chen, Yan Chen, Weiqing Zhao, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 6837-6846
Open Access | Times Cited: 28
Physiological and Pathological Roles of Mammalian NEK7
Zhenzhen Sun, Wei Gong, Yue Zhang, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 28
Molecular pathological approach to cancer epigenomics and its clinical application
Yae Kanai
Pathology International (2024) Vol. 74, Iss. 4, pp. 167-186
Open Access | Times Cited: 3
SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells
Theodore Vougiouklakis, Kenbun Sone, Vassiliki Saloura, et al.
Oncotarget (2015) Vol. 6, Iss. 41, pp. 43162-43171
Open Access | Times Cited: 29
Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives
Aarajana Shrestha, Nayeon Kim, Su‐Jeong Lee, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 20, pp. 14913-14929
Closed Access | Times Cited: 22
NEK7 Promotes Pancreatic Cancer Progression And Its Expression Is Correlated With Poor Prognosis
Zilong Yan, Jianhua Qu, Zhangfu Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
In Mitosis You Are Not: The NIMA Family of Kinases in Aspergillus, Yeast, and Mammals
Scott Bachus, Drayson Graves, Lauren Fulham, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4041-4041
Open Access | Times Cited: 15
NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
Jin Wang, Simeng Chen, Min Liu, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1179-1187
Closed Access | Times Cited: 15
Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma
Sangchul Kim, Amina Bolatkan, Syuzo Kaneko, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 810-810
Open Access | Times Cited: 23
S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis
Qianqian Wang, Jianwei Zheng, June X. Zou, et al.
Chemico-Biological Interactions (2020) Vol. 317, pp. 108965-108965
Closed Access | Times Cited: 23

Scroll to top